NAFDAC recalls BP medicine linked to cancer

The National Agency for Food and Drug Administration and Control (NAFDAC) has joined other regulatory agencies worldwide to recall a blood pressure medication from the market after it was found to contain a cancer-causing chemical.

Chukwuma Muanya

Latest news today on NAFDAC

NAFDAC recalls BP medicine linked to cancer

FG recalls 2.4m bottles of codeine cough syrup

NAFDAC raises alarm over imported contaminated frozen mixed vegetable

How to outlaw counterfeit drugs in Nigeria

Stepping up efforts to tackle antimicrobial resistance

NAFDAC, CHAI present guidelines for implementation, enforcement of MAS

At induction, businesses, organisations urged to adopt BPM

NAFDAC, others caution on use of infant formula, advocate exclusive breastfeeding

NEPC tasks exporters on AGOA gains

NAFDAC enforces authentication scheme to fight drug counterfeiting

NAFDAC urges NASS to speed up amendment of laws on counterfeit drugs, substances

NAFDAC, UNIBEN, pharmacists intensify campaign against drug, substance abuse

NAFDAC D-G says Tramadol has ruined lives of promising youths

Manufacturers blame high cost of doing business on multiplicity of taxes

DG sacks NAFDAC consultants over anomalies, irregularities

Challenges of tackling prescription medicines’ abuse, other psychoactive substances, by NAFDAC

NAFDAC wants stiffer penalty for drug counterfeiters

In the codeine discourse, family matters

NAFDAC urges FG to establish institute for herbal medicine

FG took N1.1tr from May FAAC revenue before sharing, says Oye

Remi Tinubu hails fathers as pillars of families, nations

Report estimates 279 kidnappings nationwide in May

Atiku-Amaechi presidential bid unsettles ADC

The News You Need, Delivered To You.